Who is at risk for developing severe symptoms of COVID-19?
Clinical SymptomsAparna Kumar, PhD CRNP MPH
A: The CDC recently updated its list to include older adults as well as people of any age with underlying medical conditions (chronic kidney disease, chronic obstructive pulmonary disease, immunocompromised from organ transplant, obesity, serious heart conditions, sickle cell disease, and type II diabetes). This is consistent with data from early 2020 and has been Read more…
July 6, 2020
HYDROXYCHLOROQUINE FOR HOSPITALIZED COVID PATIENTS?
Treatments Uncertainty and Misinformation
Lindsey Leininger, PhD MA
THE DATA (STILL) SUGGEST “NO” New data out of the Detroit area find that hospitalized COVID patients receiving hydroxychloroquine (HCQ) were less likely to die than those not receiving the drug. Sensational headlines ensued. The scientific community sighed in disappointment and frustration. Why? (1) Administration of HCQ was NOT RANDOMIZED (2) The HCQ and non-HCQ Read more…
A: The CDC recently updated its list to include older adults as well as people of any age with underlying medical conditions (chronic kidney disease, chronic obstructive pulmonary disease, immunocompromised from organ transplant, obesity, serious heart conditions, sickle cell disease, and type II diabetes). This is consistent with data from early 2020 and has been Read more…
HYDROXYCHLOROQUINE FOR HOSPITALIZED COVID PATIENTS?
Treatments Uncertainty and MisinformationLindsey Leininger, PhD MA
THE DATA (STILL) SUGGEST “NO” New data out of the Detroit area find that hospitalized COVID patients receiving hydroxychloroquine (HCQ) were less likely to die than those not receiving the drug. Sensational headlines ensued. The scientific community sighed in disappointment and frustration. Why? (1) Administration of HCQ was NOT RANDOMIZED (2) The HCQ and non-HCQ Read more…
THE DATA (STILL) SUGGEST “NO” New data out of the Detroit area find that hospitalized COVID patients receiving hydroxychloroquine (HCQ) were less likely to die than those not receiving the drug. Sensational headlines ensued. The scientific community sighed in disappointment and frustration. Why? (1) Administration of HCQ was NOT RANDOMIZED (2) The HCQ and non-HCQ Read more…